A composition comprises a compound of Formula 1:
##STR1##
a pharmaceutically acceptable salt, hydrate, solvate, crystal form, diastereomer,
prodrug, or mixture thereof, wherein W is a nitrogen-substituted 5- or 6-membered
monocyclic ring. The compounds are of utility as modulators of kinase activity.
